$ENSG
ENSIGN GROUP, INC Stock $ensg

$ensg Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000112537623000088 Filed on April 26, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$921.3M	$886.8M
YoY Change	25.78%	24.3%
Cost Of Revenue	$717.5M	$696.3M
YoY Change	27.3%	25.32%
Gross Profit	$203.8M	$190.5M
YoY Change	20.71%	20.73%
Gross Profit Margin	22.12%	21.48%
Selling, General & Admin	$108.3M	$103.4M
YoY Change	36.24%	30.21%
% of Gross Profit	53.16%	54.25%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$17.60M	$17.11M
YoY Change	18.43%	16.6%
% of Gross Profit	8.63%	8.98%
Operating Expenses	$125.9M	$120.5M
YoY Change	33.43%	28.08%
Operating Profit	$77.87M	$74.88M
YoY Change	-0.46%	8.34%
Interest Expense	-$2.023M	$2.036M
YoY Change	-175.26%	-1.55%
% of Operating Profit	-2.6%	2.72%
Other Income/Expense, Net	$5.202M	$3.507M
YoY Change	-198.62%	-221.6%
Pretax Income	$81.05M	$78.38M
YoY Change	11.1%	18.36%
Income Tax	$16.96M	$18.41M
% Of Pretax Income	20.93%	23.49%
Net Earnings	$63.99M	$59.85M
YoY Change	10.92%	18.9%
Net Earnings / Revenue	6.95%	6.75%
Basic Earnings Per Share	$1.15	$1.08
Diluted Earnings Per Share	$1.12	$1.05
COMMON SHARES
Basic Shares Outstanding	55.98M shares	55.73M shares
Diluted Shares Outstanding	57.26M shares	57.10M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$440.0M	$347.1M
YoY Change	49.37%	33.16%
Cash & Equivalents	$420.0M	$327.0M
Short-Term Investments	$20.02M	$20.10M
Other Short-Term Assets	$41.62M	$8.051M
YoY Change	-15.26%	-75.29%
Inventory
Prepaid Expenses
Receivables	$446.0M	$444.2M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$927.6M	$830.5M
YoY Change	35.88%	31.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.781B	$1.002B
YoY Change	206.17%	10.51%
Goodwill	$76.87M	$76.87M
YoY Change	0.0%	0.0%
Intangibles	$6.272M
YoY Change
Long-Term Investments	$85.77M	$82.05M
YoY Change	114.01%	115.79%
Other Assets	$75.13M	$73.94M
YoY Change	-28.76%	-16.41%
Total Long-Term Assets	$3.025B	$3.032B
YoY Change	23.86%	25.72%
TOTAL ASSETS
Total Short-Term Assets	$927.6M	$830.5M
Total Long-Term Assets	$3.025B	$3.032B
Total Assets	$3.952B	$3.862B
YoY Change	26.49%	26.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$78.21M	$81.47M
YoY Change	29.45%	43.3%
Accrued Expenses	$503.0M	$474.8M
YoY Change	9.76%	9.75%
Deferred Revenue	$5.458M	$8.142M
YoY Change	-12.99%	17.39%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$3.883M	$3.851M
YoY Change	-1.55%	3.44%
Total Short-Term Liabilities	$619.0M	$585.3M
YoY Change	16.37%	13.97%
LONG-TERM LIABILITIES
Long-Term Debt	$147.4M	$148.3M
YoY Change	-2.45%	-2.41%
Other Long-Term Liabilities	$1.793B	$14.34M
YoY Change	15501.16%	-21.4%
Total Long-Term Liabilities	$1.940B	$162.7M
YoY Change	16784.02%	791.51%
TOTAL LIABILITIES
Total Short-Term Liabilities	$619.0M	$585.3M
Total Long-Term Liabilities	$1.940B	$162.7M
Total Liabilities	$2.565B	$2.542B
YoY Change	27.97%	28.89%
SHAREHOLDERS EQUITY
Retained Earnings	$1.064B	$1.003B
YoY Change	27.25%	28.37%
Common Stock	$440.6M	$429.8M
YoY Change	10.47%	12.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.388B	$1.318B
YoY Change
Total Liabilities & Shareholders Equity	$3.952B	$3.862B
YoY Change	26.49%	26.86%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	$63.99M	$59.85M
YoY Change	10.92%	18.9%
Depreciation, Depletion And Amortization	$17.60M	$17.11M
YoY Change	18.43%	16.6%
Cash From Operating Activities	$119.7M	$48.34M
YoY Change	42.65%	5.38%
INVESTING ACTIVITIES
Capital Expenditures	$25.36M	$26.65M
YoY Change	-216.74%	-181.13%
Acquisitions		$0.00
YoY Change		-100.0%
Other Investing Activities	-$1.102M	$357.0K
YoY Change	-83.38%	-146.73%
Cash From Investing Activities	-$26.46M	-$35.97M
YoY Change	-6.67%	-25.43%
FINANCING ACTIVITIES
Cash Dividend Paid		$3.201M
YoY Change		5.47%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net		$1.007M
YoY Change		2.86%
Cash From Financing Activities	-269.0K	-$1.674M
YoY Change	-98.55%	-85.17%
NET CHANGE
Cash From Operating Activities	119.7M	$48.34M
Cash From Investing Activities	-26.46M	-$35.97M
Cash From Financing Activities	-269.0K	-$1.674M
Net Change In Cash	93.01M	$10.70M
YoY Change	151.13%	-178.35%
FREE CASH FLOW
Cash From Operating Activities	$119.7M	$48.34M
Capital Expenditures	$25.36M	$26.65M
Free Cash Flow	$94.38M	$21.69M
YoY Change	-10.68%	-72.44%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001125376
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2465000	usd
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33757
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	ENSIGN GROUP, INC
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0861263
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	29222 Rancho Viejo Road, Suite 127
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	San Juan Capistrano
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92675
CY2023Q1	dei	City Area Code CityAreaCode	949
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	487-9500
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	ENSG
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	55984799	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	326969000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316270000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9580000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7802000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	444181000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	408432000	usd
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	20101000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	15441000	usd
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	0	usd
CY2022Q4	us-gaap	Prepaid Taxes PrepaidTaxes	4643000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	39246000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	36339000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	830497000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	781125000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1002052000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	992010000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1790498000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1450995000	usd
CY2023Q1	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	82052000	usd
CY2022Q4	ensg	Insurance Subsidiary Deposits And Investments InsuranceSubsidiaryDepositsAndInvestments	67652000	usd
CY2023Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	39596000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	39643000	usd
CY2023Q1	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	34343000	usd
CY2022Q4	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	37291000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2359000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2465000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	76869000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	76869000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3972000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3972000	usd
CY2023Q1	us-gaap	Assets Assets	3862238000	usd
CY2022Q4	us-gaap	Assets Assets	3452022000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	81466000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	77087000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	261323000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	289810000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77419000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65796000	usd
CY2023Q1	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	50280000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	48187000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	110938000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	97309000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3851000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3883000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	585277000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	582072000	usd
CY2023Q1	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	148339000	usd
CY2022Q4	ensg	Long Term Debt Net Of Current Maturities And Debt Discount LongTermDebtNetOfCurrentMaturitiesAndDebtDiscount	149269000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1676987000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1355113000	usd
CY2023Q1	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	94023000	usd
CY2022Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	83495000	usd
CY2023Q1	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	37858000	usd
CY2022Q4	ensg	Deferred Rent And Other Long Term Liabilities DeferredRentAndOtherLongTermLiabilities	33273000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	2542484000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2203222000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59276000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55907000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	59029000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	55661000	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	60000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	59000	usd
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	429783000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	415560000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	1002976000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	946339000	usd
CY2023Q1	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3369000	shares
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	3368000	shares
CY2023Q1	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	114646000	usd
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	114626000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1318173000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	1247332000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	1581000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	1468000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1319754000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1248800000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3862238000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3452022000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	886841000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	713445000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	696326000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	555641000	usd
CY2023Q1	ensg	Rent Cost Of Services RentCostOfServices	46637000	usd
CY2022Q1	ensg	Rent Cost Of Services RentCostOfServices	35762000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	51891000	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	38256000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17112000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14676000	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	811966000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	644335000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	74875000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	69110000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2036000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2068000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5543000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-816000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	3507000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2884000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	78382000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	66226000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18413000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16138000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	59969000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	50088000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	117000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-252000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54667000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57098000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56871000	shares
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1248800000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2654000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	5068000	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	20000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0575
CY2023Q1	us-gaap	Dividends Dividends	3215000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6573000	usd
CY2023Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	77000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	117000	usd
CY2023Q1	ensg	Noncontrolling Interest Distributions To Noncontrolling Interest Holders And Other Changes NoncontrollingInterestDistributionsToNoncontrollingInterestHoldersAndOtherChanges	2000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1319754000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1021714000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	2768000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	5241000	usd
CY2022Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	15000	usd
CY2022Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.0550
CY2022Q1	us-gaap	Dividends Dividends	3042000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5167000	usd
CY2022Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	9882000	usd
CY2022Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	26000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-252000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1072013000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	59969000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	50088000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17112000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14676000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	269000	usd
CY2022Q1	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	223000	usd
CY2023Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	263000	usd
CY2022Q1	ensg	Non Cash Lease Expense NonCashLeaseExpense	124000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	47000	usd
CY2022Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	264000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1887000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2142000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6573000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5167000	usd
CY2023Q1	ensg	Gain Loss On Insurance Claims And Disposal Of Assets GainLossOnInsuranceClaimsAndDisposalOfAssets	-62000	usd
CY2022Q1	ensg	Gain Loss On Insurance Claims And Disposal Of Assets GainLossOnInsuranceClaimsAndDisposalOfAssets	-4054000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37136000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	14117000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-4643000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Taxes IncreaseDecreaseInPrepaidTaxes	-5452000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3444000	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3580000	usd
CY2023Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	10084000	usd
CY2022Q1	us-gaap	Life Insurance Corporate Or Bank Owned Change In Value LifeInsuranceCorporateOrBankOwnedChangeInValue	7916000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	9826000	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	7801000	usd
CY2023Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-6567000	usd
CY2022Q1	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-162000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4278000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1467000	usd
CY2023Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-28648000	usd
CY2022Q1	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-28989000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	13850000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	10416000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-813000	usd
CY2022Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3042000	usd
CY2023Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	9369000	usd
CY2022Q1	us-gaap	Increase Decrease In Self Insurance Reserve IncreaseDecreaseInSelfInsuranceReserve	4740000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	48344000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45874000	usd
CY2023Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	26651000	usd
CY2022Q1	ensg	Payments To Acquire Property And Equipment PaymentsToAcquirePropertyAndEquipment	15838000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	16400000	usd
CY2023Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	0	usd
CY2022Q1	ensg	Payments To Acquire Asset Acquisitions PaymentsToAcquireAssetAcquisitions	17010000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	0	usd
CY2022Q1	us-gaap	Payments For Proceeds From Deposits On Real Estate Acquisitions PaymentsForProceedsFromDepositsOnRealEstateAcquisitions	400000	usd
CY2023Q1	ensg	Proceeds From Sales Of Assets And Insurance Proceeds Investing Activities ProceedsFromSalesOfAssetsAndInsuranceProceedsInvestingActivities	13000	usd
CY2022Q1	ensg	Proceeds From Sales Of Assets And Insurance Proceeds Investing Activities ProceedsFromSalesOfAssetsAndInsuranceProceedsInvestingActivities	431000	usd
CY2023Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	9767000	usd
CY2022Q1	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	2340000	usd
CY2023Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	791000	usd
CY2022Q1	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	2553000	usd
CY2023Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	357000	usd
CY2022Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-764000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-35971000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-48240000	usd
CY2023Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	1007000	usd
CY2022Q1	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	979000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2654000	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2768000	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	20000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	15000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
CY2022Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	9882000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	3201000	usd
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	3035000	usd
CY2023Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	4000	usd
CY2022Q1	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	0	usd
CY2023Q1	ensg	Purchases Of Non Controlling Interest PurchasesOfNonControllingInterest	77000	usd
CY2022Q1	ensg	Purchases Of Non Controlling Interest PurchasesOfNonControllingInterest	26000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	19000	usd
CY2022Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	120000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1674000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-11289000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10699000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-13655000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	316270000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	262201000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	326969000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	248546000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1769000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	2107000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	46420000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	35972000	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	4900000	usd
CY2022Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3900000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3215000	usd
CY2022Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3042000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	351100000	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	170007000	usd
CY2023Q1	ensg	Number Of Health Care Facilities NumberOfHealthCareFacilities	290	facility
CY2023Q1	ensg	Operational Skilled Nursing Beds OperationalSkilledNursingBeds	29900	bed
CY2023Q1	ensg	Operational Senior Living Units OperationalSeniorLivingUnits	3000	senior_living_unit
CY2023Q1	ensg	Number Of Real Estate Properties Leased NumberOfRealEstatePropertiesLeased	211	facility
CY2023Q1	ensg	Number Of Real Estate Properties Leased With Option To Purchase NumberOfRealEstatePropertiesLeasedWithOptionToPurchase	11	facility
CY2023Q1	ensg	Number Of Real Estate Properties Leased NumberOfRealEstatePropertiesLeased	211	facility
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	108	property
CY2023Q1	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P10Y
CY2023Q1	ensg	Lessee Operating Lease Number Of Renewal Options LesseeOperatingLeaseNumberOfRenewalOptions	1	renewal_option
CY2023Q1	us-gaap	Accounts Receivable Gross AccountsReceivableGross	453761000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimates and Assumptions</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> —</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The preparation of the Interim Financial Statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Interim Financial Statements and the reported amounts of revenue and expenses during the reporting periods. The most significant estimates in the Company’s Interim Financial Statements relate to revenue, acquired property and equipment, intangible assets and goodwill, right-of-use assets, impairment of long-lived assets, lease liabilities, general and professional liabilities, workers' compensation and healthcare claims included in accrued self-insurance liabilities, and income taxes. Actual results could differ from those estimates.</span>
CY2023Q1	ensg	Number Of Financing Leases NumberOfFinancingLeases	1	lease
CY2023Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	13765000	usd
CY2022Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10512000	usd
CY2023Q1	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1907000	usd
CY2022Q4	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1001000	usd
CY2023Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	27264000	usd
CY2022Q1	ensg	Family First Coronavirus Response Act Payments Received FamilyFirstCoronavirusResponseActPaymentsReceived	17317000	usd
CY2023Q1	ensg	Revenue Recognition Family First Coronavirus Response Act Revenue Recognized RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized	26358000	usd
CY2022Q1	ensg	Revenue Recognition Family First Coronavirus Response Act Revenue Recognized RevenueRecognitionFamilyFirstCoronavirusResponseActRevenueRecognized	17599000	usd
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	416234000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9580000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7802000	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	444181000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	408432000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	59969000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	50088000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	117000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-252000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54667000	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.08
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.92
CY2023Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	59969000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	50088000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	117000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Attributable To Noncontrolling Entity IncomeLossFromContinuingOperationsAttributableToNoncontrollingEntity	-252000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	59852000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	50340000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55300000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	54667000	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1798000	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2204000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57098000	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56871000	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.05
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.89
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1178000	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	647000	shares
CY2023Q1	us-gaap	Number Of Real Estate Properties NumberOfRealEstateProperties	108	property
CY2022Q1	ensg	Number Of Lease Arrangements NumberOfLeaseArrangements	5	lease
CY2022Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	2	segment
CY2023Q1	ensg	Skilled Service Facilities SkilledServiceFacilities	253	operation
CY2023Q1	ensg	Skilled Services And Senior Living Campuses SkilledServicesAndSeniorLivingCampuses	26	operation
CY2023Q1	ensg	Senior Living Facilities SeniorLivingFacilities	11	facility
CY2023Q1	ensg	Skilled Services And Senior Living Campuses SkilledServicesAndSeniorLivingCampuses	26	operation
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	886841000	usd
CY2023Q1	ensg	Segment Income Loss SegmentIncomeLoss	78382000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17112000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	2036000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	713445000	usd
CY2022Q1	ensg	Segment Income Loss SegmentIncomeLoss	66226000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14676000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	2068000	usd
CY2022Q1	ensg	Payments To Acquire Business And Asset Acquisitions PaymentsToAcquireBusinessAndAssetAcquisitions	33410000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1358524000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1331802000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	356472000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	339792000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1002052000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	992010000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5750000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3391000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2359000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	5750000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3285000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	404000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	176000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	234000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	234000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	234000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	234000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	234000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1013000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	2359000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	76869000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	76869000	usd
CY2023Q1	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3972000	usd
CY2022Q4	us-gaap	Indefinite Lived Intangible Assets Excluding Goodwill IndefiniteLivedIntangibleAssetsExcludingGoodwill	3972000	usd
CY2023Q1	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	3548000	usd
CY2022Q4	us-gaap	Debt Issuance Costs Line Of Credit Arrangements Net DebtIssuanceCostsLineOfCreditArrangementsNet	3753000	usd
CY2023Q1	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	13765000	usd
CY2022Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10512000	usd
CY2023Q1	us-gaap	Other Restricted Assets OtherRestrictedAssets	6441000	usd
CY2022Q4	us-gaap	Other Restricted Assets OtherRestrictedAssets	6446000	usd
CY2023Q1	us-gaap	Security Deposit SecurityDeposit	2538000	usd
CY2022Q4	us-gaap	Security Deposit SecurityDeposit	2527000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	8051000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	14053000	usd
CY2023Q1	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	34343000	usd
CY2022Q4	ensg	Restricted And Other Assets Noncurrent RestrictedAndOtherAssetsNoncurrent	37291000	usd
CY2023Q1	ensg	Quality Assurance Fee QualityAssuranceFee	8486000	usd
CY2022Q4	ensg	Quality Assurance Fee QualityAssuranceFee	7701000	usd
CY2023Q1	ensg	Resident Refunds Payable ResidentRefundsPayable	41617000	usd
CY2022Q4	ensg	Resident Refunds Payable ResidentRefundsPayable	40783000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8142000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9698000	usd
CY2023Q1	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1907000	usd
CY2022Q4	ensg	Accrued Liabilities State Relief Contract Liabilities AccruedLiabilitiesStateReliefContractLiabilities	1001000	usd
CY2023Q1	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	6683000	usd
CY2022Q4	ensg	Cash Held In Trust For Residents CashHeldInTrustForResidents	6400000	usd
CY2023Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3215000	usd
CY2022Q4	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	3201000	usd
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	8075000	usd
CY2022Q4	us-gaap	Accrual For Taxes Other Than Income Taxes Current And Noncurrent AccrualForTaxesOtherThanIncomeTaxesCurrentAndNoncurrent	10926000	usd
CY2023Q1	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	13850000	usd
CY2022Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	0	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4620000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4553000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	14343000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13046000	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	110938000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	97309000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	18413000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	16138000	usd
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.235
CY2022Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.244
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3851000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3883000	usd
CY2023Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3074000	usd
CY2022Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3119000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	148339000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	149269000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	3851000	usd
CY2023Q1	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	6710000	usd
CY2023Q1	ensg	Number Of Option Plans NumberOfOptionPlans	1	plan
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.416
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.002
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.018
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y1M6D
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate	0.423
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.003
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	89.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	41.60
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	164000	shares
CY2022Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	79.79
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	33.56
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3833000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	46.72
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2069000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	28.87
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	222000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	89.84
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	19000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	61.44
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	145000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	18.26
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3891000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	50.17
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2058000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	31.41
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	3891000	shares
CY2023Q1	ensg	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Fair Value ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeFairValue	79310000	usd
CY2023Q1	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	2058000	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	176518000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	183593000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	131960000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	136000000	usd
CY2023Q1	ensg	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	40631000	usd
CY2022Q4	ensg	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	43232000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10950000	usd
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9502000	usd
CY2023Q1	ensg	Sharebased Compensation Restricted Awards Exercise Price SharebasedCompensationRestrictedAwardsExercisePrice	0
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6573000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5167000	usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y1M6D
CY2023Q1	us-gaap	Lease Cost LeaseCost	51891000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	41437000	usd
CY2023Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	263000	usd
CY2022Q1	ensg	Deferred Rent Adjustment DeferredRentAdjustment	124000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.065
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	141572000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	188863000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	188825000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	188735000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	188219000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	186975000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1693094000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2776283000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1021877000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	1754406000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	77419000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1676987000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y6M
CY2023Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	4923000	usd
CY2022Q1	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	4289000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	15543000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	20158000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	19700000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	19468000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	19442000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Five Years LessorOperatingLeasePaymentsToBeReceivedFiveYears	19417000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received Thereafter LessorOperatingLeasePaymentsToBeReceivedThereafter	115363000	usd
CY2023Q1	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	229091000	usd
CY2023Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	37613000	usd
CY2022Q1	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	27980000	usd
CY2023Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	1239000	usd
CY2023Q1	ensg	Investment Expense Income InvestmentExpenseIncome	1280000	usd
CY2022Q1	us-gaap	Gain Loss On Investments GainLossOnInvestments	-1202000	usd
CY2022Q1	ensg	Investment Expense Income InvestmentExpenseIncome	1211000	usd
CY2023Q1	ensg	Independent Operating Subsidiaries Under Medicare Probe Reviews IndependentOperatingSubsidiariesUnderMedicareProbeReviews	17	subsidiary
CY2023Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	0	usd

Files In Submission

Name	View Source	Status
0001125376-23-000088-index-headers.html	Edgar Link	pending
0001125376-23-000088-index.html	Edgar Link	pending
0001125376-23-000088.txt	Edgar Link	pending
0001125376-23-000088-xbrl.zip	Edgar Link	pending
ensg-20230331.htm	Edgar Link	pending
ensg-20230331.xsd	Edgar Link	pending
ensg-20230331_g1.jpg	Edgar Link	pending
ensgq12023ex311.htm	Edgar Link	pending
ensgq12023ex312.htm	Edgar Link	pending
ensgq12023ex321.htm	Edgar Link	pending
ensgq12023ex322.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
ensg-20230331_cal.xml	Edgar Link	unprocessable
ensg-20230331_lab.xml	Edgar Link	unprocessable
ensg-20230331_def.xml	Edgar Link	unprocessable
ensg-20230331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ensg-20230331_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ENSG
ENSIGN GROUP, INC Stock $ensg

2023 Q2 Form 10-Q Financial Statement

#000112537623000088 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG ENSIGN GROUP, INC Stock $ensg

2023 Q2 Form 10-Q Financial Statement

#000112537623000088 Filed on April 26, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ENSG
ENSIGN GROUP, INC Stock $ensg